BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 3763811)

  • 1. Amiodarone pulmonary toxicity: clinical and subclinical features.
    Adams PC; Gibson GJ; Morley AR; Wright AJ; Corris PA; Reid DS; Campbell RW
    Q J Med; 1986 May; 59(229):449-71. PubMed ID: 3763811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life-threatening postoperative pulmonary complications in patients with previous amiodarone pulmonary toxicity undergoing cardiothoracic operations.
    Nalos PC; Kass RM; Gang ES; Fishbein MC; Mandel WJ; Peter T
    J Thorac Cardiovasc Surg; 1987 Jun; 93(6):904-12. PubMed ID: 3573800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytologic changes in bronchoalveolar lavage in amiodarone treated patients].
    Jolly E; Belloti MS; Lowenstein J; Luna C; Avagnina A; Elsner B; Mazzei JA
    Medicina (B Aires); 1991; 51(1):19-25. PubMed ID: 1921687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
    Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
    Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pneumopathies induced by amiodarone. Clinical, paraclinical and physiopathological data. Apropos of 2 cases].
    Dimitriou R; Mallion JM; Perdrix A; Brambilla C; Barnoud D; De Gaudemaris R; Paramelle B
    Arch Mal Coeur Vaiss; 1985 Feb; 78(2):261-5. PubMed ID: 3920997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone lung toxicity: role of pulmonary function tests.
    Foresti V; Carini L; Lovagnini-Scher CA; Parisio E; Scolari N; Pozzi G; Clini V
    Int J Clin Pharmacol Res; 1987; 7(5):373-80. PubMed ID: 3667010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between amiodarone-induced subclinical lung toxicity and Th1/Th2 balance.
    Kuruma T; Maruyama T; Hiramatsu S; Yasuda Y; Yasuda S; Odashiro K; Harada M
    Int J Cardiol; 2009 May; 134(2):224-30. PubMed ID: 18584899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early diagnosis of amiodarone-induced pulmonary toxicity: are repeated lung function tests of any value?].
    Ulrik CS; Aldershvile J
    Ugeskr Laeger; 1996 Jun; 158(24):3445-7. PubMed ID: 8650812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pneumonitis induced by amiodarone].
    Terra Filho M; Vargas FS; Cukier A; Teixeira LR; Pinto RM; Pileggi F
    Arq Bras Cardiol; 1989 Oct; 53(4):201-5. PubMed ID: 2483501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects of amiodarone pulmonary toxicity.
    Kennedy JI
    Clin Chest Med; 1990 Mar; 11(1):119-29. PubMed ID: 2182273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-induced pulmonary diseases: diagnostic, therapeutic and prognostic aspects. Apropos of 10 personal case reports].
    Chabot F; Aymard B; Lesur O; Kheir A; Moreau L; Cornette A; Gerard H; Delorme N; Polu JM
    Rev Mal Respir; 1992; 9(6):593-601. PubMed ID: 1281922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amiodarone: a new etiology of diffuse interstitial pneumopathy? Apropos of 2 personal cases and 10 cases from the literature].
    Vergnon JM; Wiesendanger T; Bellemin JP; Brune J
    Rev Mal Respir; 1984; 1(1):43-50. PubMed ID: 6463349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amiodarone pulmonary toxicity].
    Mazzei L; Sposato B; Propati A; Gidaro M; Sciotto V; De Angelis G
    Recenti Prog Med; 1999 Dec; 90(12):658-62. PubMed ID: 10676107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary toxicity of amiodarone].
    Sevillano Martín C; Callol Sánchez L; Calderón Alvarez J; Moreno Muro M; Gómez de Terreros FJ
    Rev Clin Esp; 1989 Nov; 185(7):362-5. PubMed ID: 2623252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone lung: pathologic findings in clinically toxic patients.
    Myers JL; Kennedy JI; Plumb VJ
    Hum Pathol; 1987 Apr; 18(4):349-54. PubMed ID: 3557438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Steroid-refractory amiodarone-induced pulmonary fibrosis. Clinical features and morphology after an amiodarone-free interval of 3 months].
    Esinger W; Schleiffer T; Leinberger H; Hertrich F; Köhler G; Gröger C; Raute-Kreinsen U
    Dtsch Med Wochenschr; 1988 Oct; 113(42):1638-41. PubMed ID: 3181014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone-related pulmonary mass and unique membranous glomerulonephritis in a patient with valvular heart disease: Diagnostic pitfall and new findings.
    Kimura T; Kuramochi S; Katayama T; Yoshikawa T; Yamada T; Ueda Y; Okada Y
    Pathol Int; 2008 Oct; 58(10):657-63. PubMed ID: 18801087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of amiodarone pulmonary toxicity.
    Martin WJ
    Clin Chest Med; 1990 Mar; 11(1):131-8. PubMed ID: 2182274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.